|
Drug Safety/Pharmacovigilance |
Medicines save and improve the quality of life for untold millions every day. But they also come with risk – and the pharmaceutical industry has come under intense scrutiny for not spelling these out. Transparency, side effects, misuse and inconsistent effectiveness are among stakeholders many drug safety concerns. We’ve supported efforts to address these by:
- Coordinating communications that support global safety-related product announcements, regulatory communications and worldwide product withdrawals
- Designing risk management programs to encourage appropriate use
- Supporting large collaborative surveillance programs
- Establishing corporate guidelines for monitoring and reporting safety information in digital channels
- Creating transparency guidelines for adverse event collection and reporting
- Convening a Washington forum with major opinion leaders and journalists to discuss treatment issues
- Conducting crisis preparedness and simulation exercises in multiple geographies
- Creating programs to protect and enhance a pharmacist’s obligation to provide counsel in-pharmacy to patients
|